For instance, the use of dupilumab in AD, which targets the IL-4/IL-13 axis, can trigger PSO flares in patients with a prior history of PSO, and in some cases, even induce “de novo” PSO in AD patients with no previous history of PSO [10]. This evidence concerns the gene IL4 and Alzheimer disease.